What’s behind PE’s latest health-kick?

This week’s blog comes from Matt Bartell, EY’s UKI Transaction Advisory Life Sciences Leader and Paddy Moser, co-leader of UKI Transaction Advisory Private Equity.  There’s no doubt that health is one of the biggest stories in private equity right now. In the second quarter, the healthcare sector accounted for almost a quarter of global PE … More What’s behind PE’s latest health-kick?

Is your M&A strategy too safe?

This week’s blog comes from Julie Hood, Global Deputy Vice Chair of Transaction Advisory Services at EY. We’re all wrestling with how to future-proof our businesses. Digitisation and convergence have created bigger sector ecosystems with nimbler predators. The risk of being blindsided by a new technology or start-up has never been greater. Corporate longevity has … More Is your M&A strategy too safe?